Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
0.4100
-0.0400 (-8.89%)
Apr 1, 2025, 4:00 PM EST - Market closed

Lineage Cell Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Cash & Equivalents
45.7935.4411.3655.7432.59
Upgrade
Short-Term Investments
2.020.0546.522.628.98
Upgrade
Cash & Short-Term Investments
47.8135.4957.8858.3641.56
Upgrade
Cash Growth
34.69%-38.67%-0.83%40.41%35.31%
Upgrade
Accounts Receivable
0.640.750.350.840
Upgrade
Receivables
0.640.750.350.840
Upgrade
Prepaid Expenses
2.552.21.832.352.36
Upgrade
Restricted Cash
----0.08
Upgrade
Total Current Assets
5138.4460111.5544
Upgrade
Property, Plant & Equipment
4.44.775.674.875.63
Upgrade
Goodwill
10.6710.6710.6710.6710.67
Upgrade
Other Intangible Assets
46.5446.5646.6946.8247.03
Upgrade
Other Long-Term Assets
0.610.580.630.630.62
Upgrade
Total Assets
113.22101.02123.66174.55107.95
Upgrade
Accounts Payable
1.172.052.393.542.61
Upgrade
Accrued Expenses
4.264.226.2224.253.67
Upgrade
Short-Term Debt
----0.52
Upgrade
Current Portion of Leases
1.150.880.950.830.76
Upgrade
Current Unearned Revenue
7.3910.819.4218.120.19
Upgrade
Other Current Liabilities
---0.380.01
Upgrade
Total Current Liabilities
13.9817.9618.9847.127.77
Upgrade
Long-Term Leases
1.362.072.941.972.54
Upgrade
Long-Term Unearned Revenue
14.4318.6927.7332.45-
Upgrade
Long-Term Deferred Tax Liabilities
0.270.272.082.082.08
Upgrade
Other Long-Term Liabilities
6.16-00.030.44
Upgrade
Total Liabilities
36.213951.7383.6512.82
Upgrade
Common Stock
484.72451.34440.28434.53393.94
Upgrade
Retained Earnings
-403.47-384.86-363.37-337.1-294.08
Upgrade
Comprehensive Income & Other
-2.88-3.07-3.57-5.21-3.67
Upgrade
Total Common Equity
78.3863.4273.3492.2296.2
Upgrade
Minority Interest
-1.37-1.4-1.4-1.32-1.07
Upgrade
Shareholders' Equity
77.0162.0271.9490.995.13
Upgrade
Total Liabilities & Equity
113.22101.02123.66174.55107.95
Upgrade
Total Debt
2.512.953.92.83.83
Upgrade
Net Cash (Debt)
45.2932.5453.9855.5637.74
Upgrade
Net Cash Growth
39.19%-39.72%-2.84%47.22%47.71%
Upgrade
Net Cash Per Share
0.230.190.320.340.25
Upgrade
Filing Date Shares Outstanding
228.36188.53170.15169.71161.64
Upgrade
Total Common Shares Outstanding
220.42174.99170.09169.48153.1
Upgrade
Working Capital
37.0220.4841.0264.4336.23
Upgrade
Book Value Per Share
0.360.360.430.540.63
Upgrade
Tangible Book Value
21.176.1915.9834.7338.5
Upgrade
Tangible Book Value Per Share
0.100.040.090.200.25
Upgrade
Machinery
4.133.613.263.473.63
Upgrade
Leasehold Improvements
2.32.312.152.542.47
Upgrade
Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q